DAX+0,31 % EUR/USD-0,06 % Gold-1,02 % Öl (Brent)-0,19 %

Invictus MD Strategies - Cannabis (Seite 4)


WKN: A2N89T | Symbol: 8IS2
0,267
25.06.19
Tradegate
-1,47 %
-0,004 EUR

Neuigkeiten zur Invictus MD Strategies Aktie


Begriffe und/oder Benutzer

 

Antwort auf Beitrag Nr.: 59.578.094 von urpferdchen am 07.01.19 20:04:18Sehr schöne Erholung. Bin gespannt was der Grund dafür sein wird. Jeden Tag geht es nach oben und die anderen Canabiswerte laufen nicht so gut. Da kommt sicher bald etwas handfestes!
Antwort auf Beitrag Nr.: 59.600.099 von Koepenicker am 10.01.19 11:14:04Das ist relativ bei Invictus - die sind viel tiefer gefallen als andere Cannabiswerte - das ist auch eine
technische Erholung zu den anderen Cannabiswerten - plus die Meldungen der letzten Tage - nun
kommt es darauf an ob es erst die Kurslücke schließt.
Invictus hätte eigentlich nicht unter die 1,07 $ fallen dürfen - fundamental und im Vergleich zu den
meisten anderen Werten.
Gestern war ein starker Cannabis - Tag für alle Werte - der Marktführer Canopy mit 13 % plus - wenn
die den Trend nach oben fortsetzen werden die anderen Mitlaufen.


Antwort auf Beitrag Nr.: 59.600.744 von urpferdchen am 10.01.19 12:19:19Warum läuft Invictus so bescheiden? News fehlen ebenfalls?
Antwort auf Beitrag Nr.: 60.163.395 von Koepenicker am 21.03.19 16:58:31Weil es ein bescheidener Wert ist - oder sind die Produktionszahlen gut ?
Trend fallend - bisher
Antwort auf Beitrag Nr.: 60.163.452 von urpferdchen am 21.03.19 17:03:55
Es kommt etwas Bewegung in den Wert!
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aGENE-2746574

Invictus MD Strategies to develop CBD-infused sodas

2019-04-23 10:03 ET - News Release


Mr. George Kveton reports

INVICTUS TO DEVELOP CBD-INFUSED SODAS WITH ROCK ICON GENE SIMMONS AND SIMMONS' MONEYBAG SODAS

Invictus MD Strategies Corp. has entered into a letter of intent (LOI) to form a joint venture with Gene Simmons, Mr. Simmons's MoneyBag Soda brand and Rock Steady Sodas Inc. to develop a line of non-alcoholic, cannabidiol-infused beverages for distribution in the United States and Canada.

The economics of the of the joint venture will be determined over the next 60 days as the parties finalize due diligence. Each of the parties will contribute the following to the joint venture in exchange for their respective economic interest:

Invictus will contribute procurement of CBD and contracted expertise in infusing beverages.
Mr. Simmons and MoneyBag will contribute the licence to use the trademark Simmons MoneyBag Soda.
Rock will contribute expertise with existing premium soda recipes to be used with CBD as well as generations of bottling and distribution experience.
Currently, Mr. Simmons's line of MoneyBag sodas includes a cola, diet cola, root beer, ginger ale and cream soda. There are new flavours in development.

MoneyBag sodas are made in co-operation with Rock Steady Sodas, which is based in Niagara Falls, N.Y. The sodas are sold throughout the United States in thousands of retail locations, including: Wegmans, Hy-Vee, Meijer Foods, Tops Markets, 7-11, Yokes Fresh Markets, Big-Y, Rocket Fizz and Bridge Street Markets. They will soon be available in additional major retail chains in Canada, the United States and the Caribbean.

Mr. Simmons is an international rock legend and co-founder of Kiss, America's No. 1 gold-record-award-winning group of all time in all categories (RIAA). As a serial entrepreneur, Mr. Simmons has achieved success that reaches far beyond his music career, extending into television, film, publishing, merchandising, restaurants and consumer products. His Kiss-related achievements are astounding in themselves, with the band having sold more than 100 million albums; building a merchandising/licensing empire with over 5,000 licences, including everything from T-shirts and comic books to pinball machines, credit cards and lunch boxes; and breaking box office records set by The Beatles and Elvis.

"Based on his successes on and off the stage, we initially approached Gene to become chief evangelist officer of Invictus, but his role has grown far beyond that," commented George E. Kveton, chief executive officer of Invictus. "Simmons's MoneyBag sodas are exceptional, and working with Rock and their notable distribution channels, new line of CBD-infused sodas will catapult our growth and position in the CBD beverage space."

Mr. Simmons commented: "Invictus has a great platform to assist Rock with the procurement and launching of a new CBD beverage line under the MoneyBag Soda brand. We launched this brand in 2018 and have seen tremendous growth in sales and distribution in a very short amount of time. A CBD line will directly attach to our existing distribution channels, and the premium quality of the products will provide customers with an exceptional experience every time."

About Invictus MD Strategies Corp.

Invictus MD Strategies is a global cannabis company offering a selection of products under a wide range of brands. The company's integrated sales approach is defined by five pillars of distribution, including medical, adult use, international, licensed producer to licensed producer and retail stores.

Invictus MD Strategies has partnered with business leaders to convey its corporate vision, including Kiss music legend and business mogul Gene Simmons as its chief evangelist officer. To meet growing demand, Invictus MD Strategies is expanding its cultivation footprint, with three cannabis production facilities licensed under the Cannabis Act and Cannabis Regulations in Canada.

© 2019 Canjex Publishing Ltd. All rights reserved.
Antwort auf Beitrag Nr.: 59.584.901 von weber38 am 08.01.19 16:08:07https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aGENE-277…
Invictus's Phase 1, 2 Anlagen sind voll in Produktion

2019-06-12 09:40 ET - Pressemitteilung


Herr Trevor Dixon berichtet

AKTUALISIERUNG VON ACREAGE PHARMS LTD.

Die Phase-1- und Phase-2-Anlagen der hundertprozentigen Tochtergesellschaft von Invictus MD Strategies Corp., Acreage Pharms Ltd., mit einer Gesamtfläche von 40.000 Quadratfuß, sind jetzt voll in Produktion und beginnen mit dem dritten Erntezyklus ab ihrer elften Blüte Räume. Phase 2 wurde am 31. August 2018 für die Produktion unter Health Canadas Access to Cannabis for Medical Purposes Regulations (ACMPR) lizenziert und erntet derzeit vier Räume pro Monat. Die Gesamtproduktion von Trockenknospen und trockenem Cannabis für die kohlendioxidkritische Gasextraktion von Acreage Pharms liegt mittlerweile bei über 200 Kilogramm pro Monat. Phase 1 und Phase 2 erfüllen die geplante Produktion von 2.400 Kilogramm pro Jahr. Acreage Pharms erzielt im Durchschnitt einen Preis von 5,95 USD pro verkauftem Gramm trockener Knospen.

© 2019 Canjex Publishing Ltd. Alle Rechte vorbehalten.


Beitrag zu dieser Diskussion schreiben